Skip to content

Apotheek De Vijzel

Active
Private limited companyfounded 2010active for 16 yearsDorp 15, 2980 Zoersel, BelgiumKBO/BCE: BE 0822.951.661
Summary

Apotheek De Vijzel has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €207,405 and a net result of €3,164. Equity is growing by about 9.3% per year across the filed financial years. Its solvency ranks better than 54% of 12,713 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Risk analysisFollow ReportCompare
Apotheek De VijzelActiveChecked score 85/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
Size
≈ €1.1mturnover 2025, estimated
Staff
3.6 FTE
Equity
€207,405
Profit
€3,164
Turnover estimated from the gross margin
Financial health
85 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Structure
2025 accounts on time2 of 4 deeds summarised
Why 85raises riskNo registered site in the KBOSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 1.54, cash €144,997Founded in 2010Show the evidence

Checked score

Score 2025
85 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 42% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Average
Solvency 66-5
equity 40.7% of total assets
Liquidity 55+1
short-term debt 58.6% · cash 28.5%
Profitability 33-7
return on assets 0.6%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,259 companies, NACE 47, micro)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025lowest value 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.3%▲ +0.1 percentage points vs 06-2025 08-2025: 0.6%▲ +0.3 percentage points vs 07-2025highest value 09-2025: 0.2%▼ -0.4 percentage points vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.3%▲ +0.1 percentage points vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.3%● unchanged vs 09-2026
Credit of up to €17,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.54, compared with 1.69 in 2024, above the usual 1.5; short-term debt: 58.6% and cash: 28.5% of total assets), but 59.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 56% on solvency, 61% on liquidity, 26% on profitability and 24% on growth.

The bankruptcy probability was computed on 28-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 1.54, cash €144,997
NBB · annual accounts
raises risk · No registered site in the KBO
KBO · seat and establishments
lowers risk · Founded in 2010
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
on the day
2024
12 days late
2023
29 days late
2022
29 days late
2021
30 days late
2020
20 days late
2019
2 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 17 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 August (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
29-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Appointments: Vincent Vingerhoets (director) and Margot…Gazette deed

Key points

  • Board2 directors in office 2 View
  • Total assets 20256 financial years filed €509,493 View
  • Active since 2010founded 05-02-2010 16 years View

By topic

Financials

Financial year
2025
Total assets
€509,493
Profit
€3,164
Solvency
40.7%
Total assets▼ 0.8%
Net result
20182025
Go to Financials

Timeline

Events
23
Since
2012
Next accounts
by 31-07-2027
  1. 29-08-2024Annual accounts filed
  2. 31-12-2023Back to profit
  3. 31-12-2023Equity above €200,000
Go to Timeline

Company details

Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
05-02-2010
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about Apotheek De Vijzel

What is the company number of Apotheek De Vijzel?
0822.951.661. In Belgium the VAT number is the company number with BE in front: BE 0822.951.661.
Where is Apotheek De Vijzel based?
The registered office is at Dorp 15, 2980 Zoersel.Company details
What does Apotheek De Vijzel do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek De Vijzel?
Private limited company (BV).
When was Apotheek De Vijzel founded?
On 05-02-2010.
Is Apotheek De Vijzel still active?
Yes, Apotheek De Vijzel is an active enterprise in the KBO register.
How many employees does Apotheek De Vijzel have?
On average 3.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Apotheek De Vijzel?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is Apotheek De Vijzel profitable?
In financial year 2025, Apotheek De Vijzel made a profit of €3,164.
Where can I find the annual accounts of Apotheek De Vijzel?
Apotheek De Vijzel filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Apotheek De Vijzel due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to Apotheek De Vijzel

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure